Cargando…

Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse

Background: Novel psychoactive substances (NPS) are compounds of natural and synthetic origin, similar to traditional drugs of abuse. NPS are involved in a contemporary trend whose origin lies in a thinner balance between legitimate therapeutic drug research and legislative control. The contemporary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Correia, Beatriz, Fernandes, Joana, Botica, Maria João, Ferreira, Carla, Quintas, Alexandre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950629/ https://www.ncbi.nlm.nih.gov/pubmed/35323718 http://dx.doi.org/10.3390/medicines9030019

Ejemplares similares

Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK
por: Gittins, Rosalind, et al.
Publicado: (2018)

Misuse of prescription medicines is as prevalent as the use of recreational drugs and novel psychoactive substances in Singapore: an unrecognised public health issue?
por: Chan, Wui Ling, et al.
Publicado: (2020)

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances
por: Di Trana, Annagiulia, et al.
Publicado: (2020)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

Protocol for a scoping review on misuse of psychoactive medicines and its consequences
por: Araújo, Ana Carmona, et al.
Publicado: (2022)

ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
por: Engelgardt, Piotr, et al.
Publicado: (2022)

Novel Psychoactive Substances and Behavioral Addictions
por: Martinotti, Giovanni, et al.
Publicado: (2014)

Editorial: Pharmacology of new psychoactive substances
por: Lutfy, K., et al.
Publicado: (2023)

Psychoactive substances and the political ecology of mental distress
por: Aggarwal, Sunil K, et al.
Publicado: (2012)

PSYCHOACTIVE SUBSTANCE USE AMONG MEDICAL STUDENTS
por: Ali, R.V. Zulfikar, et al.
Publicado: (1994)

Banning Psychoactive Substances: A Slippery Slope
Publicado: (2015)

Priapism associated with novel psychoactive substance abuse
por: Jones, Patrick, et al.
Publicado: (2015)

An Expanding World of Novel Psychoactive Substances: Opioids
por: Zawilska, Jolanta B.
Publicado: (2017)

Experimentation with psychoactive substances by public school students
por: de Andrade, Maria Eliane, et al.
Publicado: (2017)

New Psychoactive Substances: A Matter of Time
por: Pantano, Flaminia, et al.
Publicado: (2019)

New psychoactive substances: a review and updates
por: Shafi, Abu, et al.
Publicado: (2020)

Psychoactive Substances Taken with Mephedrone and HCV Infection
por: Ordak, Michal, et al.
Publicado: (2021)

Molecular Insights on New Psychoactive Substances (NPSs)
por: Busardò, Francesco Paolo, et al.
Publicado: (2022)

An Update on Psychoactive Substances: Pharmacology and Toxicology Issues
por: Chiappini, Stefania, et al.
Publicado: (2023)

Genotoxicity Evaluation of The Novel Psychoactive Substance MTTA
por: Lenzi, Monia, et al.
Publicado: (2023)

Psychoactive Substances of Natural Origin: Toxicological Aspects, Therapeutic Properties and Analysis in Biological Samples
por: Gonçalves, Joana, et al.
Publicado: (2021)

Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016
por: Deen, Adrian A, et al.
Publicado: (2021)

Correction: Protocol for a scoping review on misuse of psychoactive medicines and its consequences
Publicado: (2022)

New Psychoactive Substances: A Potential Threat to Developing Countries
por: Hasan, Mehedi, et al.
Publicado: (2023)

Editorial: Old and new psychoactive substances: Pharmacology and potential applications
por: Mayer, Felix P., et al.
Publicado: (2023)

A STUDY OF COMORBIDITY IN PSYCHOACTIVE SUBSTANCE DEPENDENCE PATIENTS
por: Kisore, Pankaj, et al.
Publicado: (1994)

Prevalence of psychoactive substance use among youth in Rwanda
por: Kanyoni, Maurice, et al.
Publicado: (2015)

Effect of Different Psychoactive Substances on Serum Biochemical Parameters
por: Sanli, Dilek Beker, et al.
Publicado: (2015)

Novel psychoactive substances: What educators need to know
por: Patterson, ZR, et al.
Publicado: (2016)

Sex and Gender Differences in the Effects of Novel Psychoactive Substances
por: Fattore, Liana, et al.
Publicado: (2020)

Sudanese Medical Students’ Perceptions of Psychoactive Substance Use
por: Ibn Auf, Anas, et al.
Publicado: (2020)

Stress and psychoactive substance use among university professors
por: Vieira, Alcivan Nunes, et al.
Publicado: (2021)

An Update on the Implications of New Psychoactive Substances in Public Health
por: Simão, Ana Y., et al.
Publicado: (2022)

Prevalence of consumption of psychoactive substances among construction workers
por: LARAQUI, OMAR, et al.
Publicado: (2021)

Spirituality and the Use of Psychoactive Substances: The Perspective of Polish Students
por: Chrost, Marzena, et al.
Publicado: (2023)

Psychoactive substance use among medical residents in Tunisia
por: Masmoudi, R., et al.
Publicado: (2022)

Mood Fluctuation and Psychobiological Instability: The Same Core Functions Are Disrupted by Novel Psychoactive Substances and Established Recreational Drugs
por: Parrott, Andrew C.
Publicado: (2018)

Medical use and misuse of psychoactive prescription medications among US youth and young adults
por: Agaku, Israel, et al.
Publicado: (2021)

Psychoactive substance use among students: A cross‐sectional analysis
por: Perino, Justine, et al.
Publicado: (2022)

Psychoactive drugs and driving
por: Parekh, Vanita
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_49ispu20sigd6dfe7bopnpl4hn